logo-loader
HealthCannabis
Heritage Cannabis

Heritage Cannabis sign deal to work with Canntab Therapeutics

Heritage Cannabis (CSE:CANN) President and CEO Clint Sharples and Canntab Therapeutics (CSE:PILL) CFO Richard Goldstein joined Christine Corrado from Proactive Investors New York to talk about their partnership that seems to really benefit both companies.

Heritage’s subsidiary Purefarma Solutions will provide
processing services for hemp supplied by Canntab, to their specification, as required for the production of Canntab’s planned ingestible oral cannabis products.

Quick facts: Heritage Cannabis

Price: $0.36

Market: CSE
Market Cap: $155.05 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Heritage Cannabis named herein, including the promotion by the Company of Heritage Cannabis in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Heritage Cannabis and Empower Clinics team up for production...

Heritage Cannabis (CSE: CANN) CEO Clint Sharples and Empower Clinics (CSE: CBDT) Chairman and CEO Steven McAuley join sat down with Steve Darling from Proactive Vancouver to discuss their Joint Venture for production of CBD oil at Empower’s facility in Oregon. Sharples tells Proactive how...

4 days, 21 hours ago

2 min read